Gilead Sciences CFO Andrew D. Dickinson exercised Options for 2,797 shares on September 10, 2026, and later reported ownership of 168,443 shares. The transaction also involved 25,054 derivative securities, while a separate entry recorded 1,347 forfeited shares at $144.81 per share, giving investors updated visibility into his holdings.

Key Highlights

  • Andrew D. Dickinson’s exercised options represented about 1.7% of his resulting share holding.
  • His 1,347-share forfeiture represented about 0.8% of his prior share holding and was recorded at $144.81 per share.
  • Dickinson owned 25,054 derivative securities after exercising options for 2,797 derivative securities, representing about 10.0% of his prior derivative holdings.

GILEAD SCIENCES, INC. (NASDAQ: GILD) CFO Andrew D. Dickinson exercised options for 2,797 shares on September 10, 2026. The transaction left Dickinson with 168,443 shares, while a separate entry recorded the forfeiture of 1,347 shares at $144.81 per share.

Option Exercise and Forfeiture Details

The recorded exercise covered both Gilead Sciences shares and 2,797 derivative securities. Following the share transaction, Dickinson held 168,443 shares, equivalent to about 1.7% of his resulting share position. After that transaction, Dickinson’s reported share ownership stood at 167,096 shares, and the forfeited amount represented about 0.8% of his prior share holding. His derivative securities position after the option exercise was 25,054, representing about 10.0% of his prior derivative securities holding.